NDC 17033-030 - Vetropolycin HC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-030
- Package NDCs from labels
- 17033-030-38
- Manufacturer
- Dechra Veterinary Products | Altaire Pharmaceuticals, Inc. | Xellia Pharmaceuticals Inc. | Pharmacia and Upjohn Company | Xellia Pharmaceuticals AS
- Effective date
- 2019-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vetropolycin HC | Dechra Veterinary Products | Altaire Pharmaceuticals, Inc. | Xellia Pharmaceuticals Inc. | Pharmacia and Upjohn Company | Xellia Pharmaceuticals AS | 2019-06-07 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | A-S Medication Solutions | c895676f-446a-4a93-a3d2-addcce96b108 | 2023-01-23 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | A-S Medication Solutions | 03321951-e338-4955-8622-0f5ea29c6cd9 | 2023-01-18 | Adverse reactions | 3X7931PO74 |
| Radiaura Skin Recovery | LIDOCAINE HCL - HYDROCORTISONE ACETATE | PureTek Corporation | c9502692-674d-e53f-e053-2a95a90a74b3 | 2023-01-11 | Warnings, Adverse reactions | 3X7931PO74 |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| BHI Skin | BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR | MediNatura Inc | 70ab2931-bd2d-43de-bb36-d019f78e3d73 | 2022-07-07 | Warnings | 4T6H12BN9U |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | 4T6H12BN9U T5L8T28FGP |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Padagis US LLC | 2fdb9940-6da8-49b0-a236-9817943f7a4b | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | Proficient Rx LP | 1252b997-3a81-4f3c-90e4-92f29ba15713 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Proficient Rx LP | d1f55327-156f-44cd-b0fc-b1a938e8aa73 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | APNAR PHARMA LP | cb60f2a6-8bab-c0f9-e053-2a95a90a422a | 2022-03-16 | Adverse reactions | 3X7931PO74 |
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | 89Y4M234ES 057Y626693 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.